Q
A
CannaInvestor Magazine: What legal and compliance challenges do you anticipate when launching your platform in the United States and internationally?
Cannalogue: Cannabis regulations move quickly, so we’ve learned to be adaptable. Though hemp-derived CBD is federally legal currently in the US, this may change. Many companies may have to undergo new licensing certification processes, but fortunately we are experienced in operating in a heavily regulated framework. Additionally, each state has its own medical/recreational cannabis framework which we’ll have to navigate as well where we’re well equipped from dealing with the Canadian regulatory landscape. International markets further differ, but our approach remains identifying problems in the current regulatory framework, solving those problems with our technology, communicating with the regulatory body, and obtaining appropriate certification. We’ve proven we can reshape the regulations in Canada and can do it again in a foreign jurisdiction as we globally scale.
Q
CannaInvestor Magazine: How do you plan on being proactive and compliant?
A
Cannalogue: We know the regulatory landscape can change at any moment. Fortunately, our technology is built in-house and can be adapted to any environment. Our multidisciplinary team is agile consisting of physicians and in-house software engineers among experts in other sectors. Our platform is HIPAA and PIPEDA compliant with multiple layers of cybersecurity where team members come from the healthcare and banking sectors.